Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...
Mayo

Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...

1800 × 1200 px October 12, 2024 Zeus

Tremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ... is a high-quality image in the Mayo collection, available at 1800 × 1200 pixels resolution — ideal for both digital and print use.

Learn what Tremfya is used for in treating plaque psoriasis and psoriatic arthritis. Discover how this biologic medication works to manage your symptoms.

Image Details

TitleTremfya: First Fully Under-the-Skin IL-23 Inhibitor Shot Approved for Ulcerative Colitis and ...
Dimensions1800 × 1200 px
CategoryMayo
PublishedOctober 12, 2024
AuthorZeus
Downloads1,789
Views1,581

Frequently Asked Questions

This image has a resolution of 1800 × 1200 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Mayo collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 1800 × 1200 px.
Yes! Scroll down to the More Images section below to explore related Mayo images. You can also visit the full article for more context and a complete image gallery.

Read full article: What Is Tremfya Used For